Qie Shuo
Department of Pathology, Tianjin Medical University Cancer Institute and Hospital, Huanhuxi Road, Tiyuanbei, Hexi District, Tianjin 300060, China.
National Clinical Research Center for Cancer, Huanhuxi Road, Tiyuanbei, Hexi District, Tianjin 300060, China.
Cancers (Basel). 2022 Apr 25;14(9):2133. doi: 10.3390/cancers14092133.
Fbxo4, also known as Fbx4, belongs to the F-box protein family with a conserved F-box domain. Fbxo4 can form a complex with S-phase kinase-associated protein 1 and Cullin1 to perform its biological functions. Several proteins are identified as Fbxo4 substrates, including cyclin D1, Trf1/Pin2, p53, Fxr1, Mcl-1, ICAM-1, and PPARγ. Those factors can regulate cell cycle progression, cell proliferation, survival/apoptosis, and migration/invasion, highlighting their oncogenic or oncogene-like activities. Therefore, Fbxo4 is defined as a tumor suppressor. The biological functions of Fbxo4 make it a potential candidate for developing new targeted therapies. This review summarizes the gene and protein structure of Fbxo4, the mechanisms of how its expression and activity are regulated, and its substrates, biological functions, and clinicopathological importance in human cancers.
Fbxo4,也称为Fbx4,属于具有保守F-box结构域的F-box蛋白家族。Fbxo4可与S期激酶相关蛋白1和Cullin1形成复合物以发挥其生物学功能。几种蛋白质被鉴定为Fbxo4的底物,包括细胞周期蛋白D1、Trf1/Pin2、p53、Fxr1、Mcl-1、ICAM-1和PPARγ。这些因子可调节细胞周期进程、细胞增殖、存活/凋亡以及迁移/侵袭,突出了它们的致癌或类癌基因活性。因此,Fbxo4被定义为一种肿瘤抑制因子。Fbxo4的生物学功能使其成为开发新的靶向治疗方法的潜在候选者。本综述总结了Fbxo4的基因和蛋白质结构、其表达和活性的调控机制、其底物、生物学功能以及在人类癌症中的临床病理重要性。